Relay Therapeutics (RLAY) Income Statement (2019 - 2026)
Income Statement report data from Mar 31, 2019 to Mar 31, 2026 for Relay Therapeutics (RLAY).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||||||
Total Revenue | 3.00M (-57.14%) | 7.00M | - | 680K (-91.15%) | 7.68M | - | - | - | 10M | - | 25M (+20900.00%) | 120K (-47.83%) | 230K (-8.00%) | 250K (-26.47%) | 340K (-8.11%) | 370K (-11.90%) | 420K (-26.32%) | 570K (-14.93%) | 670K (-20.24%) | 840K (-11.58%) | 950K (-98.85%) | 83M | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||||||||||||||||||
Research And Development | 71M (+27.32%) | 55M (-18.81%) | 68M (+6.82%) | 64M (-13.43%) | 74M (+8.42%) | 68M (-11.15%) | 77M (-16.71%) | 92M (+11.64%) | 82M (+6.32%) | 78M (-4.90%) | 81M (-7.61%) | 88M (+6.48%) | 83M (+23.11%) | 67M (+0.57%) | 67M (+10.56%) | 61M (+17.11%) | 52M (-0.46%) | 52M (+15.43%) | 45M (-0.40%) | 45M (+47.45%) | 31M (-4.67%) | 32M (+31.75%) | 24M (+12.51%) | 22M (-0.14%) | 22M (-39.13%) | 36M (+95.24%) | 18M (+11.34%) | 16M | - |
Selling General And Administrative | 11M (-9.74%) | 12M (+0.74%) | 12M (-11.01%) | 14M (-27.27%) | 19M (+10.89%) | 17M (-14.43%) | 20M (-1.94%) | 20M (+1.72%) | 20M (+18.07%) | 17M (-9.30%) | 18M (-8.10%) | 20M (+2.76%) | 20M (+19.61%) | 16M (+1.87%) | 16M (-8.01%) | 17M (+8.71%) | 16M (+3.34%) | 16M (+5.93%) | 15M (+1.80%) | 14M (+13.19%) | 13M (-18.07%) | 16M (+27.15%) | 12M (+102.15%) | 6.05M (+27.10%) | 4.76M (-27.66%) | 6.58M (+80.27%) | 3.65M (+3.99%) | 3.51M | - |
Operating Expenses | 82M (+20.64%) | 68M (-15.87%) | 80M (+3.70%) | 78M (-16.24%) | 93M (+8.91%) | 85M (-11.82%) | 96M (-4.36%) | 101M (+0.39%) | 100M (+8.86%) | 92M (-6.66%) | 99M (-6.96%) | 106M (+4.70%) | 101M (+38.71%) | 73M (-15.24%) | 86M (+10.31%) | 78M (+23.82%) | 63M (-7.54%) | 68M (+10.75%) | 62M (-68.29%) | 194M (+348.39%) | 43M (-9.04%) | 48M (+30.21%) | 37M (+32.07%) | 28M (+4.76%) | 26M (-37.36%) | 42M (+92.79%) | 22M (+10.05%) | 20M | - |
Depreciation And Amortization | 500K (-78.72%) | 2.35M | - | - | 1.21M (-70.27%) | 4.07M | - | - | 1.40M (-65.60%) | 4.07M | - | - | 1.20M (-62.03%) | 3.16M | - | - | 980K (-67.44%) | 3.01M | - | - | 920K (-65.80%) | 2.69M | - | - | 860K (-69.82%) | 2.85M | - | - | - |
Operating Income | |||||||||||||||||||||||||||||
Operating Income | -78.59M (+29.62%) | -60.63M (-24.58%) | -80.39M (+4.61%) | -76.85M (-9.45%) | -84.87M (-0.13%) | -84.98M (-11.82%) | -96.37M (-4.36%) | -100.76M (+11.51%) | -90.36M (-2.00%) | -92.20M (+25.31%) | -73.58M (-30.62%) | -106.05M (+4.81%) | -101.18M (+38.89%) | -72.85M (-15.18%) | -85.89M (+10.38%) | -77.81M (+24.06%) | -62.72M (-7.38%) | -67.72M (+11.03%) | -60.99M (-68.49%) | -193.58M (+356.56%) | -42.40M | 35M | -36.61M (+32.07%) | -27.72M (+4.76%) | -26.46M (-37.34%) | -42.23M (+92.74%) | -21.91M (+10.10%) | -19.90M | - |
Ebit | -78.59M (+29.62%) | -60.63M (-24.58%) | -80.39M (+4.61%) | -76.85M (-9.45%) | -84.87M (-0.13%) | -84.98M (-11.82%) | -96.37M (-4.36%) | -100.76M (+11.51%) | -90.36M (-2.00%) | -92.20M (+25.31%) | -73.58M (-30.62%) | -106.05M (+4.81%) | -101.18M (+38.89%) | -72.85M (-15.18%) | -85.89M (+10.38%) | -77.81M (+24.06%) | -62.72M (-7.38%) | -67.72M (+11.03%) | -60.99M (-68.49%) | -193.58M (+356.56%) | -42.40M | 35M | -36.61M (+32.07%) | -27.72M (+4.76%) | -26.46M (-5.67%) | -28.05M (+28.02%) | -21.91M (+10.10%) | -19.90M (+40.34%) | -14.18M |
EBITDA | -78.09M (+9.99%) | -71.00M (-4.25%) | -74.15M (+5.37%) | -70.37M (-15.89%) | -83.66M (-14.39%) | -97.72M (+10.92%) | -88.10M (-4.46%) | -92.21M (+3.64%) | -88.97M (-14.05%) | -103.51M (+57.48%) | -65.73M (-33.27%) | -98.50M (-1.48%) | -99.98M (+38.02%) | -72.44M (-13.94%) | -84.17M (+9.61%) | -76.79M (+24.36%) | -61.75M (-5.09%) | -65.06M (+6.95%) | -60.83M (-68.55%) | -193.40M (+366.14%) | -41.49M | 36M | -36.08M (+35.03%) | -26.72M (+4.38%) | -25.60M (-14.12%) | -29.81M (+51.55%) | -19.67M (+12.14%) | -17.54M (+23.70%) | -14.18M |
Other Income / Expenses | |||||||||||||||||||||||||||||
Other Non Operating Income | 5.30M (-79.82%) | 26M (+320.83%) | 6.24M (-3.55%) | 6.47M (-17.05%) | 7.80M (-77.56%) | 35M (+320.82%) | 8.26M (-3.39%) | 8.55M (-4.79%) | 8.98M (-71.06%) | 31M (+295.79%) | 7.84M (+3.84%) | 7.55M (+8.79%) | 6.94M (-20.87%) | 8.77M (+409.88%) | 1.72M (+68.63%) | 1.02M (+50.00%) | 680K (-18.07%) | 830K (+418.75%) | 160K (-11.11%) | 180K (-18.18%) | 220K (-93.49%) | 3.38M (+537.74%) | 530K (-47.00%) | 1.00M (-36.31%) | 1.57M (-82.04%) | 8.74M (+290.18%) | 2.24M (-5.49%) | 2.37M | - |
Net Income | |||||||||||||||||||||||||||||
Net Income From Continuing Operations | -73.29M (+33.52%) | -54.89M (-25.97%) | -74.15M (+5.37%) | -70.37M (-8.68%) | -77.06M (+1.39%) | -76.00M (-13.73%) | -88.10M (-4.46%) | -92.21M (+13.29%) | -81.39M (-2.52%) | -83.49M (+27.02%) | -65.73M (-33.27%) | -98.50M (+4.52%) | -94.24M (+39.61%) | -67.50M (-19.81%) | -84.17M (+9.61%) | -76.79M (+23.76%) | -62.05M (-8.02%) | -67.46M (+10.90%) | -60.83M (-68.55%) | -193.40M (+358.51%) | -42.18M | 35M | -36.08M (+35.03%) | -26.72M (+7.35%) | -24.89M (+4.10%) | -23.91M (+21.56%) | -19.67M (+12.14%) | -17.54M (+23.70%) | -14.18M |
Net Income | -73.29M (+33.52%) | -54.89M (-25.97%) | -74.15M (+5.37%) | -70.37M (-8.68%) | -77.06M (+1.39%) | -76.00M (-13.73%) | -88.10M (-4.46%) | -92.21M (+13.29%) | -81.39M (-2.52%) | -83.49M (+27.02%) | -65.73M (-33.27%) | -98.50M (+4.52%) | -94.24M (+39.61%) | -67.50M (-19.81%) | -84.17M (+9.61%) | -76.79M (+23.76%) | -62.05M (-8.02%) | -67.46M (+10.90%) | -60.83M (-68.55%) | -193.40M (+358.51%) | -42.18M | 35M | -36.08M (+35.03%) | -26.72M (+7.35%) | -24.89M (+4.10%) | -23.91M (+21.56%) | -19.67M (+12.14%) | -17.54M (+23.70%) | -14.18M |
Comprehensive Income Net Of Tax | -73.46M (-73.26%) | -274.75M (+273.86%) | -73.49M (+4.12%) | -70.58M (-7.18%) | -76.04M (-77.54%) | -338.50M (+301.73%) | -84.26M (-8.80%) | -92.39M (+12.19%) | -82.35M (-75.18%) | -331.75M (+426.25%) | -63.04M (-36.18%) | -98.78M (+10.22%) | -89.62M (-70.11%) | -299.84M (+250.08%) | -85.65M (+7.76%) | -79.48M (+13.25%) | -70.18M (-80.77%) | -365.02M (+500.76%) | -60.76M (-68.59%) | -193.47M (+358.03%) | -42.24M (-19.80%) | -52.67M (+44.18%) | -36.53M (+32.88%) | -27.49M (+15.41%) | -23.82M (-68.23%) | -74.98M (+279.84%) | -19.74M (+15.71%) | -17.06M | - |